NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
Clinical Trials
19 trialsNCT04689945 2023-01-19
ESP
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Completed
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT03564548 2021-07-28
REBORN
Tetra Bio-Pharma
Phase 2 Unknown
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT02314871 2019-03-13
Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 4 Completed
NCT03580980 2018-07-10
Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries
National Cancer Institute, Egypt
Phase NA Completed
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT03324815 2017-10-30
Methadone Associated With Morphine for Cancer Pain
Federal University of São Paulo
Phase NA Unknown
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT00446069 2016-08-29
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
Egalet Ltd
Phase 2 Completed
NCT01946555 2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT00201539 2015-04-08
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Norwegian University of Science and Technology
Phase 3 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed
NCT00306020 2012-07-04
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
Soroka University Medical Center
Phase NA Withdrawn
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed
NCT00613743 2010-01-13
Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis
University Hospital, Geneva
Phase NA Completed